Search tips
Search criteria 


Logo of oncotargetLink to Publisher's site
Oncotarget. 2017 January 17; 8(3): 5638–5639.
Published online 2017 January 16. doi:  10.18632/oncotarget.14676
PMCID: PMC5354936

Correction: Pharmacologic targeting of the PI3K/mTOR pathway controls release of angioregulators from primary human acute myeloid leukemia cells and their neighboring stromal cells

PRESENT: Due to an error during production, Figures Figures44 and and55 were displayed as duplicates.

Figure 4
Antiproliferative effects of mTOR and PI3K inhibitors on stromal cells
Figure 5
Effects of mTOR and PI3K inhibitors on constitutive release of angiogenic mediators by stromal cells

Correct: Figures Figures44 and and55 are correctly displayed below. The authors sincerely apologize for this oversight.

Original article: Oncotarget. 2013; 4(6):830-43. doi: 10.18632/oncotarget.971.

Articles from Oncotarget are provided here courtesy of Impact Journals, LLC